therapy of breast cancer with vitamin Q10 and the regression of metastases

[Guest guest]

http://www.orthomed.org/news/abstr3.htm

Progress on therapy of breast cancer with vitamin Q10 and the regression of

metastases.

Lockwood K ; Moesgaard S ; Yamamoto T ; Folkers K

 

Over 35 years, data and knowledge have internationally evolved from biochemical,

biomedical and clinical research on vitamin Q10 (coenzyme Q10; CoQ10) and

cancer, which led in 1993 to overt complete regression of the tumors in two

cases of breast cancer. Continuing this research, three additional breast cancer

patients also underwent a conventional protocol of therapy which included a

daily oral dosage of 390 mg of vitamin Q10 (Bio-Quinone of Pharma Nord) during

the complete trials over 3-5 years. The numerous metastases in the liver of a

44-year old patient disappeared, and no signs of metastases were found

elsewhere. A 49-year-old patient, on a dosage of 390 mg of vitamin Q10, revealed

no signs of tumor in the pleural cavity after six months, and her condition was

excellent. A 75-year-old patient with carcinoma in one breast, after lumpectomy

and 390 mg of CoQ10, showed no cancer in the tumor bed or metastases. Control

blood levels of CoQ10 of 0.83-0.97 and of 0.62 micrograms/ml increased to

3.34-3.64 and to 3.77 micrograms/ml, respectively, on therapy with CoQ10 for

patients A-MRH and EEL.

 

Biochem Biophys Res Commun 1995 Jul 6;212(1):172-7

 

 

 

 

Gettingwell- / Vitamins, Herbs, Aminos, etc.

 

To , e-mail to: Gettingwell-

Or, go to our group site: Gettingwell

 

 

 

 

Mail Plus - Powerful. Affordable. Sign up now